Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on June 3, 2025
Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference
GlobeNewswire
·
June 3, 2025
ATLANTA, June 03, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, today announced that CEO, …
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
GlobeNewswire
·
June 3, 2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
GlobeNewswire
·
June 3, 2025
Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a clinical-stage precision medicine company, today …
Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes
GlobeNewswire
·
June 3, 2025
Mongolian Gerbil Research Unlocks Critical Insights for Ischemic Stroke and Neurodegenerative Disease Treatments BOSTON, MASSACHUSETTS, June 03, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company …
Trethera Secures New License, Strengthening TRE-515 Intellectual Property Portfolio and Extending Market Exclusivity to 2045
GlobeNewswire
·
June 3, 2025
LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today announced it entered an exclusive, worldwide …
Visory Health Survey Reveals Critical Gap in Prescription Savings for Uninsured Spanish Speakers
GlobeNewswire
·
June 3, 2025
ESTERO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Visory Health, a patient-first health tech prescription platform that is transforming the way Veterans, families, and caregivers access affordable healthcare through its prescription discount card, today …
Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
GlobeNewswire
·
June 3, 2025
SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic …
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
GlobeNewswire
·
June 3, 2025
Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small molecule APJ agonists EMERYVILLE, Calif., June 03, 2025 ( …
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
GlobeNewswire
·
June 3, 2025
Southlake, TX, June 03, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”) powered medical technology company focused on transforming ECGs/EKGs to enable earlier detection …
L’AVENIR DE LA PRODUCTION ALIMENTAIRE EST FAIT AU CANADA : Le Défi Cultiver l’innovation d’ici offre une subvention de 20 M$ dans le cadre de sa phase de mise à l’échelle pour soutenir la production alimentaire nationale
GlobeNewswire
·
June 3, 2025
TORONTO, 03 juin 2025 (GLOBE NEWSWIRE) -- Il est plus essentiel que jamais d’assurer au Canada un approvisionnement alimentaire sécuritaire et durable. Poursuivant son engagement de longue date envers l’amélioration du bien-être des Canadiens, la Fondation …
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
GlobeNewswire
·
June 3, 2025
Screening test provides prenatal risk assessment for common genetic conditions in one blood draw without the need for paternal testing Early access via large-scale clinical study to establish the validity and utility of the FirstGeneTM screen SALT LAKE …
H1 Acquires Veda to Solve Healthcare’s Provider Data Challenge and Power Better Care
GlobeNewswire
·
June 3, 2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- H1, on a mission to connect the world with the right doctors, today announced that it has acquired Veda Data Solutions, Inc. (Veda). Backed by notable investors like Oak HC/FT and HealthX, Veda provides accurate …
THE FUTURE OF FOOD IS MADE IN CANADA: The Homegrown Innovation Challenge Launches $20M Scaling Phase Grant to Support Domestic Food Production
GlobeNewswire
·
June 3, 2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- It has never been more important for Canada to have a secure and sustainable supply of food. Building on its longstanding commitment to improving the well-being of Canadians, the Weston Family Foundation is …
BON Announces Share Repurchase Program for up to US$1.0 Million
GlobeNewswire
·
June 3, 2025
XI’AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced its board of directors approved a …
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
GlobeNewswire
·
June 3, 2025
25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000 A full 45 percent of persistent babesiosis cases include chronic fatigue Healthcare providers treating patients who present with …
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
GlobeNewswire
·
June 3, 2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“SEC”) of a registration statement on …
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
GlobeNewswire
·
June 3, 2025
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …
Nanox to Participate in Sidoti Small Cap Conference
GlobeNewswire
·
June 3, 2025
PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will participate in the Sidoti Small Cap Conference to be held …
QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency
GlobeNewswire
·
June 3, 2025
Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue. WEST PALM BEACH, FL, June 03, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), …
Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics
GlobeNewswire
·
June 3, 2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences, a global leader in the research and intellectual property of premium psilocybin products, has signed an agreement with Johns Hopkins University to exclusively license Johns Hopkins …